Loading...
XJPX2689
Market cap73mUSD
Jan 21, Last price  
1,955.00JPY
1D
0.46%
1Q
1.19%
Jan 2017
61.44%
Name

OLBA Healthcare Holdings Inc

Chart & Performance

D1W1MN
XJPX:2689 chart
P/E
7.71
P/S
0.10
EPS
253.73
Div Yield, %
4.12%
Shrs. gr., 5y
1.22%
Rev. gr., 5y
1.99%
Revenues
118.56b
+7.33%
54,378,491,00054,999,778,00058,863,158,00062,135,924,00074,744,816,00096,223,044,00097,137,879,00094,515,043,000101,460,896,000105,778,686,000107,663,554,000107,428,432,000107,896,793,000112,976,196,000107,959,426,000110,472,640,000118,564,924,000
Net income
1.50b
+6.09%
137,295,000-780,156,000223,958,000312,270,000346,030,000943,278,000816,577,000405,259,000305,711,000690,650,0001,054,046,000775,582,000326,413,000989,368,0001,535,333,0001,414,238,0001,500,356,000
CFO
2.08b
P
797,044,000738,428,0001,178,730,000207,774,0001,932,492,0002,060,516,000926,404,000-2,113,866,000710,079,000871,610,000-314,298,000136,723,000862,564,0003,126,307,0002,420,642,000-659,519,0002,084,226,000
Dividend
Jun 27, 20250 JPY/sh
Earnings
Jan 29, 2025

Profile

OLBA HEALTHCARE HOLDINGS, Inc. provides various solutions to medical institutions, universities, corporate research institutes, individuals, and long-term care facilities in Japan. The company's medical equipment business engages in the wholesale of artificial joints, pacemakers, coronary stents, steel instruments, and ultrasonic scalpels; and diagnostic imaging equipment, such as MRI and CT to respirators, intraoperative monitors, and surgical lights. It also offers reagents and equipment for genetic research, cell culture, and protein analysis; automatic analyzers for biochemistry, immunity, and blood; and test reagents, as well as undertakes services for DNA analysis in the field of life sciences. The company's Supply Processing and Distribution business provides goods management, information management, and purchase management services. Its Nursing care products business engages in the rental of nursing care equipment; sale of welfare equipment, such as portable toilets and bathing equipment; and operation of long-term care reform, a comfortable stay at home. The company was formerly known as Kawanishi Holdings, Inc. and changed its name to OLBA HEALTHCARE HOLDINGS, Inc. in January 2021. OLBA HEALTHCARE HOLDINGS, Inc. was founded in 1921 and is headquartered in Okayama, Japan.
URL
https://www.olba.co.jp/
IPO date
Dec 21, 2000
Employees
1,289
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
118,564,924
7.33%
110,472,640
2.33%
107,959,426
-4.44%
Cost of revenue
116,338,120
108,328,100
105,885,447
Unusual Expense (Income)
NOPBT
2,226,804
2,144,540
2,073,979
NOPBT Margin
1.88%
1.94%
1.92%
Operating Taxes
742,903
742,304
601,487
Tax Rate
33.36%
34.61%
29.00%
NOPAT
1,483,901
1,402,236
1,472,492
Net income
1,500,356
6.09%
1,414,238
-7.89%
1,535,333
55.18%
Dividends
(435,914)
(367,198)
(310,547)
Dividend yield
3.63%
3.37%
3.05%
Proceeds from repurchase of equity
(219,685)
26,629
(608,108)
BB yield
1.83%
-0.24%
5.98%
Debt
Debt current
738,265
1,098,263
374,154
Long-term debt
1,922,259
1,789,071
1,919,608
Deferred revenue
847,368
926,667
Other long-term liabilities
929,342
58,973
58,640
Net debt
(429,334)
(1,399,643)
(2,495,043)
Cash flow
Cash from operating activities
2,084,226
(659,519)
2,420,642
CAPEX
(477,059)
(251,002)
(453,356)
Cash from investing activities
(673,033)
(306,247)
(211,806)
Cash from financing activities
(1,089,783)
175,938
(1,169,906)
FCF
626,851
(1,161,212)
2,111,896
Balance
Cash
2,731,386
2,399,977
3,189,805
Long term investments
358,472
1,887,000
1,599,000
Excess cash
Stockholders' equity
11,609,330
10,348,151
9,153,505
Invested Capital
13,933,299
12,582,635
10,760,653
ROIC
11.19%
12.01%
13.90%
ROCE
15.62%
16.74%
19.07%
EV
Common stock shares outstanding
5,961
6,021
6,073
Price
2,016.00
11.50%
1,808.00
7.94%
1,675.00
1.21%
Market cap
12,018,176
10.41%
10,885,100
7.00%
10,172,684
1.06%
EV
11,588,842
9,485,457
7,677,641
EBITDA
2,791,670
2,654,657
2,477,427
EV/EBITDA
4.15
3.57
3.10
Interest
19,429
17,845
20,519
Interest/NOPBT
0.87%
0.83%
0.99%